EFG International AG (0QJX)
London Exchange · UK · prices in CHF · close of 21 Oct 2026
Key indicators
| Last close | CHF 16.00 |
|---|---|
| 52-week range | 15.06 – 19.90 |
| Return, 1 month / 3 months | +3.0% / −1.4% |
| Return, 1 year / 3 years | +4.7% / +75.4% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 24.7% |
| Worst drawdown (1 year) | -23.0% |
| Average daily value traded | 1.19M CHF |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EFG International is a Swiss private banking group based in Zurich. It provides private banking and asset management services to wealthy individuals, families and entrepreneurs, helping them manage their financial assets. The bank offers advisory and discretionary portfolio management, lending, and wealth planning services through offices in Switzerland and other markets around the world. Its clients are mainly private clients and external asset managers who use the bank for custody and investment services.
On this site EFG International AG appears as a stock on the London Exchange (UK), code 0QJX, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EFG International AG (0QJX) trades on the London Exchange in UK. It last closed at CHF 16.00 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,979 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.7% and over the last three months it fell 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.0% | ||
| From 52-week high | -19.4% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.4% | ||
| 6-month return | -4.5% | ||
| 12-month return, skipping the last month | 1.7% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.0% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.19M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +3.0% |
| 3 months | −1.4% |
| 6 months | −4.5% |
| 1 year | +4.7% |
| 3 years | +75.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 15.98 / 17.02 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | CHF 0.6500 |
| 25 Mar 2025 | CHF 0.6000 |
| 26 Mar 2024 | CHF 0.5500 |
| 25 Apr 2023 | CHF 0.4500 |
| 4 May 2022 | CHF 0.3600 |
| 4 May 2021 | CHF 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.